KAT2B anticorps (N-Term)
Aperçu rapide pour KAT2B anticorps (N-Term) (ABIN6735736)
Antigène
Voir toutes KAT2B AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- Recognizes the N-terminal domain of the transcriptional activator PCAF. This domain of PCAF contains a region that interacts with p300/CBP and it competes with the adenoviral E1A oncoprotein for binding to p300/CBP as a potential tumor suppressor.
-
Purification
- Protein G purified
-
Immunogène
-
N-terminal domain of human PCAF.
Type of Immunogen: Protein -
Isotype
- IgG2a
-
-
-
-
Indications d'application
-
Approved: ELISA (1:8000), WB
Usage: Suitable for use in ELISA and Western Blot. ELISA: 1:8000. -
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7.2.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
-
Short term: 4°C
Long term: Add glycerol (40-50%) -20°C.
-
-
- KAT2B (K(lysine) Acetyltransferase 2B (KAT2B))
-
Autre désignation
- KAT2B / PCAF
-
Sujet
-
Name/Gene ID: KAT2B
Synonyms: KAT2B, CREBBP-associated factor, GCN5, Histone acetyltransferase PCAF, K(lysine) acetyltransferase 2B, Lysine acetyltransferase 2B, Histone acetylase PCAF, PCAF, p300/CBP-associated factor, CAF, GCN5L -
ID gène
- 8850
-
UniProt
- Q92831
-
Pathways
- Signalisation p53, Regulation of Carbohydrate Metabolic Process
Antigène
-